skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

About Mary Jo

Washington DC, {6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+19 year(s) experience

Mary Jo Laffler
Mary Jo oversees commercial and R&D news for Informa’s pharmaceutical publications, working with a talented group of reporters and editors covering business and clinical topics. While she has a wide-ranging knowledge of the commercial and regulatory challenges facing the industry, her specialty is analyzing drug development news and R&D strategy.
Mary Jo previously spent more than 15 years reporting on the pharmaceutical industry, including as executive editor and managing editor for Pink Sheet, executive editor for Pharmaceutical Approvals Monthly, and one of the first managing editors for Pink Sheet DAILY (the latter two publications are now part of Pink Sheet content). These roles involved following the drug development process from clinical trials to FDA review to approval and launch, as well as keeping track of broad industry trends and the commercial landscape. This broad experience helps to inform our current coverage. Mary Jo supported development of the FDA Performance Tracker and enjoys working with data to understand the trends affecting the industry.

Specialties

  • Policy & Regulation
  • Biopharma Pipeline Strategy
  • Commercial Strategy

Mary Jo Writes For

Analyst Articles

Articles by Mary Jo